Additionally, considering the association between NF2 loss-of-function and deficient BCR signaling and the crucial role of B-cells in enhancing T-cell-mediated anti-cancer immunity [24,47], the combination of intact NF2 with activated YAP signaling pathways may provide a better stratification of MPM patients responsive to ICB. This evidence concerns the gene YAP1 and cancer.